Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) - Total Liabilities
Based on the latest financial reports, Shanghai Aladdin Biochemical Technology Co. Ltd. A (688179) has total liabilities worth CN¥1.42 Billion CNY (≈ $207.52 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Shanghai Aladdin Biochemical Technology to track the company's year-over-year net asset growth rate.
Shanghai Aladdin Biochemical Technology Co. Ltd. A - Total Liabilities Trend (2019–2025)
This chart illustrates how Shanghai Aladdin Biochemical Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See 688179 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Shanghai Aladdin Biochemical Technology Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shanghai Aladdin Biochemical Technology Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Doosan Pref Shs
KO:000155
|
Korea | ₩20.11 Trillion |
|
Aussie Broadband Ltd
AU:ABB
|
Australia | AU$511.64 Million |
|
Guangxi Wuzhou Zhongheng Group Co Ltd
SHG:600252
|
China | CN¥3.65 Billion |
|
ASA Gold and Precious Metals Ltd
NYSE:ASA
|
USA | $2.11 Million |
|
Cymbria Corporation
TO:CYB
|
Canada | CA$138.94 Million |
|
Supalai Public Company Limited
BK:SPALI-R
|
Thailand | ฿44.32 Billion |
|
CATARC Automotive Proving Ground Co.Ltd.
SHE:301215
|
China | CN¥575.08 Million |
|
Hangzhou Jingye Intelligent Technology Co. Ltd. A
SHG:688290
|
China | CN¥493.75 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Shanghai Aladdin Biochemical Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688179 company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai Aladdin Biochemical Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai Aladdin Biochemical Technology Co. Ltd. A (2019–2025)
The table below shows the annual total liabilities of Shanghai Aladdin Biochemical Technology Co. Ltd. A from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.49 Billion ≈ $218.51 Million |
+135.07% |
| 2024-12-31 | CN¥635.25 Million ≈ $92.96 Million |
+35.40% |
| 2023-12-31 | CN¥469.15 Million ≈ $68.65 Million |
-6.92% |
| 2022-12-31 | CN¥504.03 Million ≈ $73.75 Million |
+583.09% |
| 2021-12-31 | CN¥73.79 Million ≈ $10.80 Million |
+57.50% |
| 2020-12-31 | CN¥46.85 Million ≈ $6.86 Million |
+5.49% |
| 2019-12-31 | CN¥44.41 Million ≈ $6.50 Million |
-- |
About Shanghai Aladdin Biochemical Technology Co. Ltd. A
Shanghai Aladdin Biochemical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of scientific research reagents in China and internationally. It offers chemistry and biochemicals reagents, including blocks, ligands, catalysts, chemical synthesis, laboratory chemicals, chemical biology, analytical standards, CVD and ALD precursors, and s… Read more